IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

NIGER, MONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.419
NA - Nord America 947
AS - Asia 522
SA - Sud America 99
OC - Oceania 13
AF - Africa 7
Totale 3.007
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 933
DE - Germania 800
CN - Cina 249
GB - Regno Unito 197
SG - Singapore 114
SE - Svezia 92
IT - Italia 90
BR - Brasile 88
IE - Irlanda 51
NL - Olanda 44
IN - India 36
RU - Federazione Russa 36
HK - Hong Kong 29
ID - Indonesia 23
FI - Finlandia 22
FR - Francia 21
JP - Giappone 15
CA - Canada 13
KR - Corea 13
BE - Belgio 12
ES - Italia 12
AT - Austria 10
AU - Australia 10
UA - Ucraina 10
PK - Pakistan 6
TH - Thailandia 5
BO - Bolivia 4
DK - Danimarca 4
TW - Taiwan 4
ZA - Sudafrica 4
BD - Bangladesh 3
IR - Iran 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
TR - Turchia 3
UZ - Uzbekistan 3
VN - Vietnam 3
AR - Argentina 2
AZ - Azerbaigian 2
HU - Ungheria 2
IQ - Iraq 2
LB - Libano 2
MA - Marocco 2
AL - Albania 1
BY - Bielorussia 1
CH - Svizzera 1
CO - Colombia 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
GR - Grecia 1
IS - Islanda 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MX - Messico 1
OM - Oman 1
PE - Perù 1
PY - Paraguay 1
RO - Romania 1
SA - Arabia Saudita 1
VE - Venezuela 1
Totale 3.007
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 742
Southend 165
Chandler 130
Fairfield 89
Ashburn 83
Singapore 61
Dublin 51
Cambridge 49
Seattle 45
Woodbridge 44
Beijing 38
Milan 38
Wilmington 38
Houston 37
New York 35
Princeton 33
Dearborn 27
Ann Arbor 26
Council Bluffs 23
Jakarta 23
Santa Clara 23
Hong Kong 18
Nanjing 18
Los Angeles 17
Phoenix 17
Bengaluru 16
Des Moines 14
Helsinki 14
Brussels 12
Shanghai 12
Cangzhou 11
Redwood City 10
Munich 9
Shenyang 8
Toronto 8
Fuzhou 7
Guangzhou 7
Falls Church 6
Grafing 6
Haikou 6
Hangzhou 6
London 6
Mountain View 6
Nuremberg 6
Rochester 6
San Diego 6
Silver Spring 6
São Paulo 6
Vienna 6
Central District 5
Erlangen 5
Hyderabad 5
Jinan 5
Oxford 5
Quanzhou 5
Seoul 5
Tokyo 5
Zhengzhou 5
Amsterdam 4
Berlin 4
Brasília 4
Bühl 4
Eitensheim 4
Tianjin 4
Wuhan 4
Ascoli Piceno 3
Belo Horizonte 3
Changsha 3
Chicago 3
Kent 3
Lisbon 3
Nanchang 3
Osaka 3
Oslo 3
Ottawa 3
Porto Alegre 3
Salvador 3
Sandwich 3
Sydney 3
The Dalles 3
Andover 2
Auckland 2
Baghdad 2
Baku 2
Bangkok 2
Campinas 2
Carrara 2
Castrocaro Terme 2
Central 2
Cochabamba 2
Curitiba 2
Goiânia 2
Guadarrama 2
Ho Chi Minh City 2
Islamabad 2
Jiaxing 2
Johannesburg 2
La Paz 2
Lappeenranta 2
Leeuwarden 2
Totale 2.228
Salva come PNG Salva come JPEG
Nome #
Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial 265
Undetected toxicity risk in pharmacogenetic testing for dihydropyrimidine dehydrogenase 262
GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab : A clinical and translational study 238
Prognostic impact of ATM mutations in patients with metastatic colorectal cancer 215
Comparative Effectiveness of Gemcitabine plus Nab-Paclitaxel and FOLFIRINOX in the First-Line Setting of Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis 198
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer 182
BRAF in metastatic colorectal cancer : the future starts now 166
Metronomic Capecitabine With Cyclophosphamide Regimen in Unresectable or Relapsed Pseudomyxoma Peritonei 161
Safety of long-term exposure to abiraterone acetate in patients with castration-resistant prostate cancer and concomitant cardiovascular risk factors 152
Targeting the PI3K/AKT/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectives 149
Maintenance Therapy with Panitumumab Alone vs Panitumumab Plus Fluorouracil-Leucovorin in Patients with RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial 138
FOLFOXIRI-Bevacizumab or FOLFOX-Panitumumab in Patients with Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer: A Propensity Score-Based Analysis 133
Ramucirumab as Second-Line Therapy in Metastatic Gastric Cancer : Real-World Data from the RAMoss Study 126
Progress in treatments for colorectal cancer peritoneal metastases during the years 2010-2015 : a systematic review 121
MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers 116
Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model 116
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index 116
A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer 108
Preoperative Capecitabine, Oxaliplatin, and Irinotecan in Resectable Gastric or Gastroesophageal Junction Cancer: Pathological Response as Primary Endpoint and FDG-PET Predictions 97
Outpatient palliative care referral system (PCRS) for patients with advanced cancer: an impact evaluation protocol 33
Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors: the phase Ib trial MetNET2 25
The potential role of metformin in the treatment of patients with pancreatic neuroendocrine tumors: a review of preclinical to clinical evidence 13
null 3
null 1
Totale 3.134
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.562
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.562
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202040 0 0 0 0 0 0 0 0 0 0 24 16
2020/2021203 15 15 13 3 22 27 11 26 26 22 6 17
2021/2022266 27 10 11 23 18 18 9 18 19 34 14 65
2022/2023401 57 52 41 32 35 78 9 18 46 7 21 5
2023/2024765 7 14 17 25 88 22 106 105 53 103 114 111
2024/2025806 95 111 85 121 57 48 79 64 40 98 8 0
Totale 3.134